Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel M Chu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Reviews. Cancer|March 21, 2008
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapyIsabel M Chu, Ludger Hengst, Joyce M Slingerland
Cell Cycle (Georgetown, Tex.)|May 20, 2011
BMI1 suffers a degrading experienceMark Hoenerhoff, Isabel M Chu, Jeffrey E Green
Plos One|April 12, 2013
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFßIsabel M Chu, Wei-Chu Lai, Olga Aprelikova, et al.
Scientific Reports|August 23, 2016
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialJason J Lohmueller, Shuji Sato, Lana Popova, et al.
Breast Cancer Research : BCR|July 21, 2012
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancerChristina N Bennett, Christine C Tomlinson, Aleksandra M Michalowski, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Reviews. Cancer|March 21, 2008
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapyIsabel M Chu, Ludger Hengst, Joyce M Slingerland
Cell Cycle (Georgetown, Tex.)|May 20, 2011
BMI1 suffers a degrading experienceMark Hoenerhoff, Isabel M Chu, Jeffrey E Green
Plos One|April 12, 2013
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFßIsabel M Chu, Wei-Chu Lai, Olga Aprelikova, et al.
Scientific Reports|August 23, 2016
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialJason J Lohmueller, Shuji Sato, Lana Popova, et al.
Breast Cancer Research : BCR|July 21, 2012
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancerChristina N Bennett, Christine C Tomlinson, Aleksandra M Michalowski, et al.
Pageof 1